HCA Holdings Inc. (NYSE:HCA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Monday. The brokerage presently has a $81.00 target price on the stock. Zacks Investment Research’s target price would suggest a potential upside of 9.46% from the company’s previous close.

According to Zacks, “HCA Inc. is a non-governmental hospital in the U.S. providing health care and related services. The Company operates a network of acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. The Company also owns and manages freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, and various other facilities. HCA Inc. is headquartered in Nashville, Tennessee. “

Several other equities analysts also recently weighed in on the company. KeyCorp raised HCA Holdings from a “sector weight” rating to an “overweight” rating and set a $94.00 price target for the company in a research report on Thursday, October 13th. Mizuho downgraded HCA Holdings from a “buy” rating to a “neutral” rating in a research report on Wednesday, November 9th. Jefferies Group reissued a “buy” rating on shares of HCA Holdings in a research report on Tuesday, September 6th. JPMorgan Chase & Co. downgraded HCA Holdings from an “overweight” rating to a “neutral” rating and set a $85.00 price target for the company. in a research report on Friday, July 29th. Finally, Evercore ISI initiated coverage on HCA Holdings in a research report on Thursday, September 22nd. They set a “hold” rating and a $89.00 price target for the company. Nine analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $87.30.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Shares of HCA Holdings (NYSE:HCA) opened at 74.00 on Monday. The company has a 50 day moving average price of $76.82 and a 200 day moving average price of $77.23. HCA Holdings has a 12-month low of $60.07 and a 12-month high of $83.69. The stock has a market cap of $27.73 billion, a P/E ratio of 11.71 and a beta of 0.79.

HCA Holdings (NYSE:HCA) last released its quarterly earnings results on Thursday, October 27th. The company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.19. The company earned $10.27 billion during the quarter, compared to the consensus estimate of $10.41 billion. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. HCA Holdings’s revenue was up 4.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.17 earnings per share. Analysts anticipate that HCA Holdings will post $6.71 earnings per share for the current fiscal year.

In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Friday, October 28th. The stock was sold at an average price of $79.41, for a total transaction of $170,731.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider A Bruce Moore, Jr. sold 167,967 shares of the business’s stock in a transaction dated Wednesday, November 9th. The stock was sold at an average price of $73.65, for a total value of $12,370,769.55. Following the transaction, the insider now owns 207,682 shares in the company, valued at approximately $15,295,779.30. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Nuveen Asset Management LLC boosted its position in shares of HCA Holdings by 240.8% in the first quarter. Nuveen Asset Management LLC now owns 80,095 shares of the company’s stock worth $6,251,000 after buying an additional 56,595 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of HCA Holdings by 34.8% in the first quarter. Envestnet Asset Management Inc. now owns 32,829 shares of the company’s stock worth $2,562,000 after buying an additional 8,467 shares in the last quarter. A.R.T. Advisors LLC boosted its position in shares of HCA Holdings by 1,231.2% in the first quarter. A.R.T. Advisors LLC now owns 58,278 shares of the company’s stock worth $4,548,000 after buying an additional 53,900 shares in the last quarter. Stonerise Capital Management LLC boosted its position in shares of HCA Holdings by 188.9% in the first quarter. Stonerise Capital Management LLC now owns 260,000 shares of the company’s stock worth $20,293,000 after buying an additional 170,000 shares in the last quarter. Finally, Eachwin Capital LP bought a new position in shares of HCA Holdings during the first quarter worth approximately $550,000. Institutional investors own 71.43% of the company’s stock.

HCA Holdings Company Profile

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.